Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-049230

Director bought 108,601 shares at $23.02 ($2,499,995)

From the SEC's structured data for this filing

Trades in this filing

SCHIFF ANDREW N · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-08-16 Purchase : show line 1 in the form +108,601 $23.02 $2,499,995 634,455 I
Open-market purchases · 108,601 sh · avg $23.02 · $2,499,995
Loading xslF345X03/doc4.xml…